New England Biolabs

Founded in 1974, New England Biolabs (NEB) is a privately held, globally recognized producer and supplier of recombinant and native enzyme reagents. The company is a cornerstone in the life science research community, providing critical tools that advance fields like genome editing, synthetic biology, and next-generation sequencing. NEB's extensive catalog includes enzymes, DNA/RNA modifying reagents, and molecular biology kits, all developed with a focus on purity, performance, and innovation to support scientific discovery worldwide.

With a robust operational presence spanning 8 locations and a dedicated workforce of 500-1,000 employees, New England Biolabs ensures broad accessibility to its scientific resources. The company actively contributes to the research ecosystem by offering free access to vital bioinformatics tools such as REBASE, InBASE, and Polbase, which are indispensable for molecular biology research. This commitment to open science and community support is a defining characteristic of NEB's operational philosophy. To understand the expertise behind these contributions, consider exploring Meet New England Biolabs's team.

Operating within the Pharmaceuticals and Healthcare sectors, New England Biolabs achieved a revenue of $137.4M. Its long-standing history since 1974 highlights its sustained impact and market presence. Beyond its commercial activities, NEB is deeply committed to environmental stewardship and advocacy, integrating sustainable practices throughout its operations. This dual focus on scientific excellence and responsible corporate citizenship positions NEB as a leader in its field.